-
Ultimovacs downsizes to funnel funds to cancer vaccine programme
17 Apr 2024 17:42 GMT
… second-line treatment in mesothelioma patients. The study … GlobalData forecasts therapeutic cancer vaccines as the weakest immuno … Arena.
Other cancer vaccines in development include Transgene … and ISA Pharmaceuticals’ cancer vaccine, ISA101b, for treating …
-
Ultimovacs Announces Topline Results from INITIUM Study Evaluating UV1 Vaccination Added to Ipilimumab and Nivolumab in Patients with Unresectable or Metastatic Malignant Melanoma
07 Mar 2024 06:25 GMT
… leader in novel immunotherapeutic cancer vaccines, today announced topline results … leader in novel immunotherapeutic cancer vaccines with broad applicability. Ultimovacs’ … for patients with malignant pleural mesothelioma. Enrollment of 118 patients …
-
Ultimovacs reports trial results of UV1 cancer vaccine
04 Mar 2024 14:13 GMT
… vaccine to second-line treatment with ipilimumab and nivolumab for pleural mesothelioma … patients.
Malignant pleural mesothelioma is an aggressive … in patients with malignant pleural mesothelioma (MPM) after first-line …
-
FDA Fast Tracks UV1 Vaccine Combo for Mesothelioma
21 Feb 2024 21:53 GMT
… pleural mesothelioma that can’t be managed with surgery.
Therapeutic cancer vaccines … , ipilimumab, and nivolumab, in malignant mesothelioma, a hard-to-treat cancer … that didn’t receive the mesothelioma vaccine.
Investigators reported that the rates …
-
Ultimovacs bags EMA orphan drug status for cancer vaccine
20 Feb 2024 16:00 GMT
… its universal cancer vaccine UV1 for the treatment of mesothelioma.
The positive … NIPU trial evaluating the vaccine in malignant pleural mesothelioma patients, according to … – one for unresectable malignant pleural mesothelioma to improve overall survival and …
-
FDA Grants Fast Track Designation to Cancer Vaccine for Malignant Pleural Mesothelioma
05 Feb 2024 23:31 GMT
… for Patients with Malignant Mesothelioma Receiving UV1 Cancer Vaccine. Ultimovacs ASA. News … for the UV1 Cancer Vaccine for Treatment of Mesothelioma. Ultimovacs ASA. News … -for-the-uv1-cancer-vaccine-for-treatment-of-mesothelioma
4. Ultimovacs Granted …
-
Phase I Trial Improves Mesothelioma Survival More Than 200%
31 Jan 2024 23:39 GMT
… vaccine.
The trial included 10 patients with relapsed or refractory mesothelioma … Patients with relapsed or refractory mesothelioma who receive standard therapy have … relapsed/refractory WT1 positive mesothelioma,” said Sterguiou.
All patients …
-
Anti-melanoma vaccine, testing begins at Pascale in Naples: first dose administered
26 Jan 2024 17:24 GMT
… experimental mRNA anti-cancer vaccine for the treatment of … drug. This anti-melanoma vaccine, produced by the American … of the first mRNA vaccine against cancer. A completely … progression, first-line pleural mesothelioma and some colorectal cancers. …
-
Huntington's Disease Market to Witness Upsurge in Growth by 2032, Predicts DelveInsight | Key Companies to Watch Out - Prilenia, Neurocrine, Annexon, SOM, Vaccinex, Sage, UniQure, Wave life sciences, Takeda, Medesis
01 Nov 2023 17:00 GMT
… Annexon Biosciences, SOM Biotech, Vaccinex, Sage Therapeutics, UniQure Biopharma … , Ionis Pharmaceuticals, Annexon, Vaccinex, Neurocrine Biosciences, SAGE Therapeutics … Polyangiitis Market | Malignant Pleural Mesothelioma Market | Nocturnal Enuresis Market …
-
Ultimovacs Rebounds on New Universal Cancer Vaccine Data for Mesothelioma
18 Oct 2023 16:03 GMT
… cancer vaccine has a benefit for deadly mesothelioma. The … pleura, eventually leading to mesothelioma tumors, this cancer … rate for localized pleural mesothelioma, the most treatable type … supports further development in mesothelioma” and will be discussing …